Quantitative Antibody Levels in Hospital Workers after Receiving three Doses of CoviD-19 vaccines
Authors:
- Pompini Agustina SitompulPSPompini Agustina Sitompul
- Nina MarianaNMNina Mariana
- Ervan BudimanEBErvan Budiman
- Dian Wahyu TanjungDTDian Wahyu Tanjung
- Betha AriesantyBABetha Ariesanty
- Teguh Sarry HartonoTHTeguh Sarry Hartono
- Jahiroh JahirohJJJahiroh Jahiroh
- Christine ErnitaCEChristine Ernita
- Anita PuspitasariAPAnita Puspitasari
- Herlina HerlinaHHHerlina Herlina
- Suliati SuliatiSSSuliati Suliati
Open Access
- 29 September 2022
- journal article
- research article
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 15 (3) , 1745-1749
Abstract
Hospital workers were at high risk for SARS-CoV-2 infection and the first population with authorized access to the three doses of vaccination against SARS-CoV-2 antigen. The study was aimed to compare SARS-CoV-2 antibody levels among hospital workers receiving the three doses of Covid-19 vaccines with a history of Covid-19 infection versus those without a history of infection. A cross sectional study was conducted at the Sulianti Saroso Infectious Disease Hospital (SSIDH) in December 2021. The inclusion criteria were hospital workers in both subjects with and without previous Covid-19 infection and those who had received 3 doses of Covid-19 vaccines. Anti SARS-CoV-2 antibody levels measured by the Architect of SARS-CoV-2 IgG II Quant. There were 75 participants in the study, the median of anti SARS CoV-2 levels reported 8724.4 AU/mL (3396.8, 15773.2 AU/mL, Interquartile range). They were divided into 2 groups according to the status of prior Covid-19 infection, hospital workers with and without previous of Covid-19 infection. There was no significance difference in antibody less than 25.000 AU/mL between hospital worker with and without previous Covid-19 infection (p=1,000). Meanwhile, the median of antibody levels was seen in the interval between the 3rd dose of vaccine within 1 month; 2 to 3 months; 4 to 5 months before the antibody measurement (14576.5 AU/mL;12407.4 AU/mL; 5778.1 AU/mL, respectively). In this study, after three doses of Covid-19 vaccines, there was no significance difference in antibody levels of hospital worker with and without previous Covid-19 infection.Keywords
This publication has 12 references indexed in Scilit:
- Are COVID-19 Vaccine Boosters Needed? The Science behind BoostersJournal of Virology, 2022
- Boosting immunity to COVID-19 vaccinesNature Medicine, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 MonthsNew England Journal of Medicine, 2021
- Effect of the third dose of BNT162b2 vaccine in quantitative SARS-CoV-2 spike 1-2 IgG antibody titers in healthcare workersmedRxiv, 2021
- Protection of BNT162b2 Vaccine Booster against Covid-19 in IsraelNew England Journal of Medicine, 2021
- Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnelInfection, 2021
- Anti-SARS-CoV-2 Antibody Levels Measured by the AdviseDx SARS-CoV-2 Assay Are Concordant with Previously Available Serologic Assays but Are Not Fully Predictive of Sterilizing ImmunityJournal of Clinical Microbiology, 2021
- Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?Infection, 2021
- Mix-and-match COVID vaccines trigger potent immune responseNature, 2021
- Clinical evaluation of the Abbott Alinity SARS-CoV-2 spike-specific quantitative IgG and IgM assays in infected, recovered, and vaccinated groupsmedRxiv, 2021